Diclofenac - NDC Database (Page 18)
50090-7855 Apr 17, 2025
Diclofenac Sodium 75 mg Oral Tablet, Delayed Release by A-s Medication Solutions
Diclofenac Sodium 75 mg Oral Tablet, Delayed Release by A-s Medication Solutions
50090-7856 Apr 17, 2025
Diclofenac Sodium 75 mg Oral Tablet, Delayed Release by A-s Medication Solutions
Diclofenac Sodium 75 mg Oral Tablet, Delayed Release by A-s Medication Solutions
50090-7880 Mar 28, 2025
Diclofenac Sodium Delayed Release 50 mg Oral Tablet, Delayed Release by A-s Medication Solutions
Diclofenac Sodium Delayed Release 50 mg Oral Tablet, Delayed Release by A-s Medication Solutions
50090-7881 Mar 28, 2025
Diclofenac Sodium Delayed Release 50 mg Oral Tablet, Delayed Release by A-s Medication Solutions
Diclofenac Sodium Delayed Release 50 mg Oral Tablet, Delayed Release by A-s Medication Solutions
50436-1003 Nov 13, 1998
Diclofenac Sodium Delayed Release 75 mg Oral Tablet, Delayed Release by Unit Dose Services
Diclofenac Sodium Delayed Release 75 mg Oral Tablet, Delayed Release by Unit Dose Services
50436-2225 Nov 20, 2017
Diclofenac Sodium 1.5% 1.5% 16.05 mg/ml Topical Solution by Unit Dose Services
Diclofenac Sodium 1.5% 1.5% 16.05 mg/ml Topical Solution by Unit Dose Services
50436-3338 Jun 04, 2021
Diclofenac Sodium 1.5% 1.5% 16.05 mg/ml Topical Solution by Unit Dose Services
Diclofenac Sodium 1.5% 1.5% 16.05 mg/ml Topical Solution by Unit Dose Services
50580-574 Jun 20, 2022
Motrin Arthritis Pain 9.3 mg/g Topical Gel by Johnson & Johnson Consumer Inc., Mcneil Consumer Healthcare Division
Motrin Arthritis Pain 9.3 mg/g Topical Gel by Johnson & Johnson Consumer Inc., Mcneil Consumer Healthcare Division
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.